Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SH3 domain binding kinase family member 3 (SBK3) is a protein-coding gene predicted to encode a serine/threonine-protein kinase with putative roles in chromatin remodeling and protein phosphorylation[2][3]. Experimental evidence indicates that SBK3 suppresses angiotensin II-induced cardiac hypertrophy, suggesting involvement in cardiovascular disease modulation[4]. Functional associations and gene ontology annotations support its classification as a kinase, but the full biological and pharmacological significance remains under investigation[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SH3 domain binding kinase family member 3 (SBK3).